Results 291 to 300 of about 131,040 (312)
Some of the next articles are maybe not open access.
Quantification in clinical fluorodeoxyglucose positron emission tomography
Nuclear Medicine Communications, 2004Positron emission tomography (PET) is increasingly used clinically to provide functional information on disease processes, especially in oncology using the glucose analogue 2-[18F]fluoro-2-deoxy-D-glucose (F-FDG). In the clinical setting it has become standard practice to use simplified imaging protocols compared to the often complex methods developed ...
openaire +2 more sources
18-Fluorodeoxyglucose imaging in oncology.
The Journal of the Oklahoma State Medical Association, 1999This article describes the use of 18-fluorodeoxyglucose (FDG) scans for the diagnostic evaluation of cancer patients. Since FDG is a positron emitting radio-pharmaceutical, a dedicated Positron Emission Tomography unit (PET) or a hybrid PET/SPECT (single photon emission computed tomography) unit is required for oncologic studies.
openaire +1 more source
Fluorodeoxyglucose Uptake in Atheroma
Journal of the American College of Cardiology, 2019Peter Libby +2 more
openaire +1 more source
18F-fluorodeoxyglucose PET/Computed Tomography
PET Clinics, 2022Stephen M. Broski +3 more
openaire +1 more source
Fluorodeoxyglucose rate constants in rat brain
Neuroscience, 1989A L, Miller, R A, Hawkins
openaire +2 more sources
[18F]Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis.
Journal of the American College of Cardiology, 2017Sung‐A Chang +9 more
semanticscholar +1 more source

